Back to search
FDAFDA · Food and drugs·Recall number D-0595-2024

Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1725-01 (vial), NDC 70710-1725-06 (outer box).

Published July 17, 2024 · Recall initiated: July 2, 2024

Summary

FDA records drug Class III recall D-0595-2024, published July 17, 2024 and initiated July 2, 2024. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Completed; Reported quantity: 12720 vials; Lot: Lot #: L300220, Exp. 05/31/2025. Class III means the product is not likely to cause adverse health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross contamination with other products

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Zydus Pharmaceuticals (USA) Inc
Distributor
Nationwide in the USA and Puerto Rico
Lot
Lot #: L300220, Exp. 05/31/2025.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1725-01 (vial), NDC 70710-1725-06 (outer box). recalled?

Yes. FDA published recall D-0595-2024 on July 17, 2024. Reported hazard: Cross contamination with other products

What should I do if I have this product?

Voluntary: Firm initiated · Letter